ARHGAP9 and hepatocellular carcinoma: Different from the above findings, another study indicated that ARHGAP9 expression was significantly lower in hepatocellular carcinoma (HCC) tissues than that in normal liver tissues, and the overall survival time of patients with lower ARHGAP9 expression was significantly shorter than those with its higher expression.